Treatment of children with familial hypercholesterolemia with colestilan, a newly developed bile acid-binding resin.
Asami
Tadashi
T
Uchiyama
Makoto
M
D000284:Administration, Oral; D000293:Adolescent; D000837:Anion Exchange Resins / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D008076:Cholesterol, HDL / Q000187:drug effects / Q000378:metabolism; D008078:Cholesterol, LDL / Q000187:drug effects / Q000378:metabolism; D003084:Colestipol / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D011336:Probability; D011446:Prospective Studies; D012494:Sampling Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014280:Triglycerides / Q000378:metabolism
D000837:Anion Exchange Resins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides; D003084:Colestipol